Snowball logo
logo
BIO_logo

Bio-Rad Laboratories, Inc

$372.43+$2.48ย  (0.67%)
Estimate
P/E
48.6
EPS
7.66
Beta
1.068
Growth
Revenue, YoY
-0.09%
Net income, YoY
16.87%
FCF, YoY
-5.79%
Forecast
P/E (FWD)
37.6
EPS (FWD)
9.917
About the company
Ticker
BIO
ISIN
US0905722072
Country
United States of America
Sector (GICS)
Healthcare
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Frequently asked questions

What sector does Bio-Rad Laboratories, Inc (BIO) operate in?

Bio-Rad Laboratories, Inc belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Bio-Rad Laboratories, Inc (BIO) current stock price?

As of the latest data, Bio-Rad Laboratories, Inc stock price is $372.43, with a previous close of $369.95. Bio-Rad Laboratories, Inc gained $2.48 in the last trading session, representing a 0.67% increase.

What is Bio-Rad Laboratories, Inc (BIO) current market capitalization?

Bio-Rad Laboratories, Inc market cap is approximately 8.08 billion.

What is Bio-Rad Laboratories, Inc (BIO) Earnings Per Share (EPS)?

The trailing EPS is $7.66, and the forward EPS is $9.92.

What is Bio-Rad Laboratories, Inc (BIO) Price-to-Earnings (P/E) ratio?

Bio-Rad Laboratories, Inc current P/E ratio is 48.62, with a forward P/E of 37.56.

What is Bio-Rad Laboratories, Inc (BIO) EBITDA?

Bio-Rad Laboratories, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 542.10 million.

Does Bio-Rad Laboratories, Inc (BIO) pay dividends?

No. Bio-Rad Laboratories, Inc does not pay a dividend.

How did Bio-Rad Laboratories, Inc (BIO) perform in its most recent earnings report?

In the last report (June 30, 2026), Bio-Rad Laboratories, Inc posted an EPS surprise of 11.97% and a revenue surprise of 4.33%.

When is Bio-Rad Laboratories, Inc (BIO) next earnings report?

Bio-Rad Laboratories, Inc is expected to release its next earnings report on September 30, 2026.

What is Bio-Rad Laboratories, Inc (BIO) beta (volatility) score?

Bio-Rad Laboratories, Inc has a beta of 1.068, meaning its volatility is roughly in line with the market.